Medicines Co. Stock
-
Your prediction
Pros and Cons of Medicines Co. in the next few years
Pros
Cons
Performance of Medicines Co. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Medicines Co. | - | - | - | - | - | - | - |
Opko Health Inc. | 1.000% | 4.613% | -8.771% | -8.282% | -4.306% | -56.468% | -29.968% |
Catalent Inc. | 0.130% | 1.247% | -1.396% | 25.589% | 31.990% | -52.298% | 25.459% |
Repligen Corp. | -0.490% | 2.893% | 0.843% | -12.500% | -21.480% | -45.799% | 93.529% |
Comments
News
Why Tandem Diabetes Care Stock Thrashed the Market Today
Tandem Diabetes Care (NASDAQ: TNDM) had some encouraging news to report on the regulatory front Thursday, and after it hit the headlines investors piled into the stock. At the end of the day the
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
Johnson & Johnson (NYSE: JNJ) is one of the world's largest healthcare companies, with a diverse product portfolio that includes pharmaceuticals, medical devices and consumer health products
Johnson & Johnson is as Cheap as it’s Going to Get
Shares of Johnson & Johnson (NYSE: JNJ) are as cheap as they will get. The stock is down in premarket trading following the Q1 release, but there is a bottom in play and reality to face. Trading